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Abstract
Objective: The European Reference Network on Rare Endocrine Conditions (Endo-ERN), 
operational since 2017, consists of 71 health care providers (HCPs) in 19 EU  
member states. Our objective was to assess education and knowledge on rare  
endocrine conditions.
Design and methods: A survey was developed and sent through the DIGIT-EUROSURVEY 
system to all Endo-ERN HCPs.
Results: Response rate was 55% (n = 146), 95% physicians, 58% >20 years of experience, 
96% academics. Largest knowledge gaps were reported for the transition and neonatal 
ages, and for the GPs. Less than 50% of HCPs had structured educational rare diseases 
(RD) plans, while 86% used RD specific guidelines. HCPs would share educational 
materials within Endo-ERN (74%), and participate in an accreditation model (85%). 
E-learning portals of the endocrine scientific societies used 58% (ESPE) and 64% (ESE). 
Most participants (90%) regarded Endo-ERN coordinated educational activities (annual 
meetings slots, webinars, etc.) as highly important and supported a common educational 
platform. Social media was perceived as important for educating patients (86%) but  
not for physicians (36%). Seventy-five % had developed patient education materials;  
only 31% had specific children’s materials, and by-country availability varied from  
0 to 100%. Respondents provided newly diagnosed patients with their own material in 
the national language (81%); referred to advocacy groups (68%), and relevant online 
sources (50%). Respondents believed the European Commission should fund education 
through Endo-ERN.
Conclusion: Identified knowledge gaps in rare endocrine disorders set the basis for fast 
catch-up through collaboration, alignment with patients’ needs, and further development 
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Patients with rare disorders (RD) are few for any given 
country, while the required care is more complex in nature 
compared to common chronic disorders (1). RDs are 
characterized by unmet educational needs and knowledge 
gaps, lack of universal diagnostic tools and complex 
management. The RD patient community is very much 
aware of this and demands the rapid improvement of care 
(www.eurordis.org). Nowadays, people with RD live longer, 
and children who might have not survived in the past need 
decent care throughout their lifespan (2). The European 
Reference Networks for rare diseases were established 
and began operating in March 2017, covering large 
geographical parts of Europe and, by definition, collecting 
best expert knowledge. The European Commission’s (EC) 
concept was primarily to reduce health care inequalities 
among member states, such as different health service and 
care development, discrepancies between health funds and 
care availability, but most of all because of the unlikely 
scenario that all countries could develop and provide the 
best expertise for rare and ultra-rare disorders (3). Networks 
were thus expected to improve cross-border health care, the 
impact of inspirational leaders and network governance 
being crucial.
From the beginning, the biggest challenge for 
the Networks was the lack of additional funding and 
uncertainties regarding national/local support, despite 11 
predefined ‘system levers’ on integrated care frameworks 
(https ://ec .euro pa.eu /heal th/si tes/h ealth /file s/sys tems_ 
perfo rmanc e_ass essme nt/do cs/20 17_bl ocks_ en_0. pdf). 
Nevertheless, the interest among health care providers 
(HCPs) was enormous. To clarify, the term HCPs stands 
for hospitals and other health establishments. The 
number of ERNs at the initiation of this very ambitious 
European project was 24, with more than 300 member 
HCPs including 900 expert units. Main requirements 
for ERN membership were RD expertise established at 
the national level, and multidisciplinary life-long care 
(3). The Networks are now in their 4th year, and various 
successful examples and positive changes in the landscape 
of RD in Europe are appearing. Moreover, on an on-going 
annual basis, the EC audits Network members, performs 
random site visits to check the accuracy of self-assessment 
documents, and has developed a continuous monitoring 
program for ERNs, that includes mandatory periodic 
reporting on 18 general key performance indicators.
A characteristic feature of rare endocrine diseases is the 
differing spectrum of disorders and patients encountered 
in pediatric compared to adult age range. In childhood, 
there is a large variety of genetic conditions, and many 
patients still die early because of delayed diagnosis or 
nonexistent treatment (4). In adulthood, patients with 
rare endocrine diseases are grouped in fewer entities, 
but in larger numbers. In-between, the age of transition 
should be covered by pediatric endocrinologists and 
endocrinologists working together. These characteristics 
were taken into account when creating the structure of 
the European Reference Network on Rare Endocrine 
Conditions (Endo-ERN), which has 8 Main Thematic 
disease Groups (MTGs) (https ://en do-er n.eu/ speci fic-e 
xpert ise/o vervi ew-mt g/). Every MTG has 4 chairs – a 
pediatric, and an adult professional, and a pediatric and 
an adult patient advocacy group (ePAGs) representative. 
The specific activities that the Network should fulfill for 
the initial 5 years of existence were defined ‘horizontally’ 
in Work Packages (WPs) – WP1: Education and Training, 
WP2: E-health and ICT, WP3: Research and Science; WP4: 
Quality of care and Patients’ views and WP5: Diagnostics 
and Laboratory Analysis. Every WP also has four chairs 
as described previously. As required, Endo-ERN Network 
is chaired by an adult endocrinologist that fully shares 
the activities with a pediatric co-chair, assuring consensus 
between parties. All chairs constitute the Steering 
Committee (SC). This structure was endorsed by both 
major European professional societies, ESPE (European 
Society of Pediatric Endocrinology) and ESE (European 
Society of Endocrinology).
As stated in the Endo-ERN network application, the 
mission is to reduce and ultimately abolish inequalities in 
care for patients with rare endocrine disorders in Europe, 
by facilitating knowledge sharing, health care and research. 
One of the first formulated and adopted tasks for WP1 
Education and Training was to assess the educational and 
knowledge gaps as well as map existing resources on rare 
endocrine conditions, by performing a survey among the 
Network members, the results of which are presented here.
Methodology
First, a representative WP1 Working group with two 
participants (one pediatric and one adult) from all 
eight MTGs was established. A maximally transparent 
procedure was followed by offering all members the 
possibility to participate, and those expressing interest 
were invited. The principles of equality by specialty (adult 
or paediatric), gender, and country/European region were 
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taken into account when composing the final members of 
the Working group. All eight MTGs were represented, 56% 
of the participants were female; 50% were pediatric and 
50% adult endocrinologists.
The first draft of the Survey was created by the WP1 
Chairs. The rationale was based on the principles for 





Compliance with the specifics of the Network was 
emphasized – equal representation of pediatric and adult 
needs, and sensitivity to patient views and demands. The 
first survey was addressed to health professionals (HPs). 
To clarify, ‘HPs’ stands for health professionals (doctors, 
nurses, etc.). We also assessed existing resources, local and 
international, self-created and translated patient and HPs 
educational materials, as well as readiness to share within 
and contribute to the Network.
To overcome some of the difficulties in developing a 
survey (diversity in the level of development of the member 
HCPs, type of diseases cared for and their rarity, some being 
ultra-rare, language and cultural traits), WP1 Chairs first 
created a basic, universal short survey, which was tested for 
feasibility and validation within the WP1 Working group.
Feasibility and validation procedures
The feasibility/validation process took place in August/
September 2017. WP1 Working group members 
(n = 20) answered the Survey questions and reported on any 
identified inconsistencies/problems. Ten answers (50%) 
were received. Through this process, mistakes, repetitions 
and missing variables, as well as unclear expressions were 
identified and corrected. The most important results of the 
feasibility/validation survey were then presented at the SC 
Meeting in October 2017. The final Survey consisted of 36 
questions, and was approved by the SC (Supplementary 
Fig. 1, see section on supplementary materials given at 
the end of this article). The DIGIT-EUSURVEY instrument 
was chosen for its known reliability, possibilities to survey 
many participants and reliable statistic output. It takes 
around 20 min to complete the survey.
Data collection and analysis
The survey was distributed on 1 November 2017 to all 
HCPs representatives of Endo-ERN. The accompanying 
e-mail explained the pre-requisite of a response from at 
least one member per MTG for the given HCP. Since most 
HCPs participate in more than one Main Thematic Group 
(MTG), the maximum expected number of respondents 
was 268 (71 HCPs, multiplied by the number of 
participating MTGs within Endo-ERN). Three reminders 
were sent, the last one on 2 December 2017. The Survey 
was closed on 1 January 2018.
Analysis was done automatically with the DIGIT-
EUROSURVEY system.
Results
Basic characteristics and demographics of 
the respondents
A total of 146 (55%) responses were received from all 19 
member countries. The three most represented countries 
were Italy (n = 31), The Netherlands (n = 22) and UK 
(n = 17) while Luxemburg and Portugal participated by 
one responder each. Respondents were predominantly 
physicians, with less than 5% other HC professionals, 53% 
were female and 96% represented University hospitals. 
Of the respondents, 36% were pediatric, 59% adult 
specialists and 5% others. Most participants were >40 
years (81%), and 58% had >20 years of practice with RD. 
The represented HCPs were evenly distributed between all 
MTGs (Fig. 1).
MTG6, pituitary, (20%) and MTG1, adrenal (19%) were 
slightly overrepresented among the individual responses, 
followed by MTG3, Genetic disorders of glucose and 
insulin homeostasis and MTG7, Sex Development and 
Maturation (12% each).
Knowledge gaps
The largest knowledge gaps in patient care were reported 
for adolescent, young adult (transition), and adult patients 
(Fig. 2). When analyzed according to the respondent’s 
specialty, pediatricians identified additional knowledge 
gaps regarding the neonatal age (49%). 
The largest knowledge and training gaps in the field 
of RD among physicians were reported for GPs (71%), 
followed by students and medical specialist trainees (61% 
each), and specialists (51%). Only 45% of the HCPs had 
a structured RD educational plan, aimed at any kind of 
medical staff; 36% reported a specific training program for 
GPs. Health personnel’s RD knowledge was periodically 
assessed through structured programs by 53% of the HCPs.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.https://doi.org/10.1530/EC-20-0480
https://ec.bioscientifica.com © 2021 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 06/01/2021 11:13:45AM
via University of Helsinki





Educational and practice needs of the physicians
The importance of different diagnostic and treatment-
related aspects of RD as rated by doctors were as follows: 
disease diagnosis: 99%; disease follow-up issues: 99%; 
available treatments: 99%; disease prognosis: 95%; 
advice from centers of excellence: 92%; local health care 
organizations: 83%; cross-border health care: 70%.
Most of the HCPs developed and used national/
local RD disease-specific guidelines, which are publicly 
available (86%); 30% had already collaborated with 
other Endo-ERN members to develop/translate/adapt 
guidelines. A considerable proportion of the HCPs 
reported to be ready to share educational materials 
within the Endo-ERN (74%), and to participate in the 
creation and application of an accreditation model 
(85%). Only 12% had a fully available repository of 
educational materials, including media coverage and lay 
public activities, and 27% had access to partial archive 
only. Intriguingly, 95% were ready to collect such 
materials in the future, and 72% were ready to share these 
within Endo-ERN.
Educational tools for physicians
Of the online available educational tools, 58% of 
the respondents (96% of pediatric and 33% of adult 
endocrinologists) consider the ESPE e-learning portal as 
more appropriate to develop as a RD learning tool, and 
64% (25% of pediatric and 90% of adult endocrinologists) 
consider the ESE e-learning platform as more appropriate. 
Other resources were used less often. In their daily 
practice with RD, HPs used and most often recommend 
trainees to use the OMIM NLM online database (>76%) 
and Orphanet (>75%). Social media were assessed by HPs 
as very important for the education of patients (86%), but 
less important for that of physicians (36%).
A unanimous wish was to have special RD boosting 
knowledge slots at the ESE/ESPE annual meetings, and 
dedicated postgraduate courses (86% each). Almost all 
answers (95%) were in favor of a common RD educational 
platform, uniform for the Network. The large majority of 
participants (90%) supported advertising different types 
of educational activities (webinars, pod-casts, lectures, 
journal clubs) through Endo-ERN.
Figure 1
Distribution of HCPs respondents by membership 

















Patient age interval least covered by enough knowledge.
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Educational needs of patients as perceived 
by doctors
Survey participants rated the following items as most 
important for patients: available treatments (99%); 
prognosis (94%); rehabilitation and everyday issues (94%); 
nature and course of the disease (88%); psychological 
aspects (85%); social and economic issues (68%).
Regarding educational materials for patients, 75% of 
respondents had developed such, 55% of which were made 
publicly available, and 30% had specific educational plans 
for ePAGs. HCPs less frequently (31%) developed/used 
specific educational materials for children. Importantly, 
the by-country availability of educational materials varied 
from 0% to 100%.
When diagnosing a new patient with RD, respondents 
usually provided their own material in the national 
language (81%); printed available online material in the 
national language (37%), or in other languages (18%); In 
addition, patients were referred to PAGs (68%), and the 
patient/family were also referred to relevant websites/
social media sources (50%).
Financing of educational activities
Opinions on how educational activities should be financed 
were assessed on a Likert scale. ‘Likely’ and ‘very likely’ 
future educational Endo-ERN funding possibilities were: 
EC funding through Endo-ERN (86%); EC educational 
calls specific for the ERNs (73%); pharma activities and 
governmental/state activities (51% each); HCPs funding 
their own activities (45%); medical schools funding 
(42%); ePAGs raised funding for education (32%).
The answer to the question whose responsibility it is 
to finance educational activities was in the vast majority of 
respondents that this should be EC funded work, through 
Endo-ERN, while only a few respondents answered that 
this could be the responsibility of the state/government, 
or that of Medical schools.
Discussion
For rare diseases, quality education achieved through 
diverse actions, acknowledging the individual needs of 
the different conditions is pivotal for sustainable health 
care systems (6). Professional education is mandatory 
for prompt diagnosis and proper management of RD. 
At the same time, patients need to understand the 
condition in order to secure best possible care and 
respond optimally to it. Our aim was to map the current 
situation and knowledge on rare endocrine conditions 
in Europe through detailed surveying core specialists 
from Endo-ERN reference centers. The approach was 
to collect as much as possible groups-of-conditions 
specific information, assuring maximal representation 
of educational needs as defined by the highest level of 
medical health professionals. Extensive clinical experience 
- also called ‘hands-on education’ (7, 8) is more important 
for professional development than the formal training 
(9). In the present study, the age of the respondents (>40 
years), and specifically their long-standing academic 
experience (>20 years) are representative of the validity of 
the collected information.
Some inequality existed in the adult and pediatric 
representation of the respondents, most probably due 
to more adult representation of specialists from the two 
MTGs (pituitary and adrenal) with the highest response 
rates. Alternatively, there is a possibility that less 
pediatric endocrinologists were addressed by the HCPs. 
Consequently, to correct for potential bias, additional 
analyses were performed according to the profession of 
the respondents. As expected, the results differed only in 
the preference of educational tools (ESPE e-learning for 
pediatric endocrinologists and ESE e-learning platform 
for adult endocrinologists), as well as in which area the 
respondents reported the lack of sufficient knowledge 
(neonatology for pediatric endocrinologists, and 
adolescence and young adulthood for both specialties). To 
our mind, these findings further underpin the importance 
of networking in order to reduce existing gaps.
Difficulties to access specific knowledge and 
competences concerning adolescence/young adulthood 
are not limited to endocrine diseases or RD only. Reported 
evidence on successful transitional health care is limited, 
and available written educational protocols are hardly 
available (10, 11). The evaluation of the knowledge and 
practice educational interventions is difficult even in case 
of existent robust outcomes (11), such as HbA1c in patients 
with diabetes (10). Even if well planned, controlled and 
documented, educational interventions are often not 
directly adding value to usual care (6). Understandably, 
every HCP is managing the process within its own 
healthcare system and accessible means, which justifies 
alignment efforts from the Network.
A recent Belgian study addressing educational needs 
of GPs (12) showed that most of them already used various 
RD information channels. However, their educational 
endeavors were prompted only by direct encounter 
with RD patients. Most of the respondents identified 
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better penetration of RD education in the academic 
medical curricula as a major lever for improvement of RD 
knowledge, as well as the introduction of so-called ‘red 
flags’, drawing attention to, and increasing awareness 
of a possible RD in the clinical practice. However, the 
participants in this study (12) were not directly involved 
in expert RD care which sharply contrasts with the 
participants of the current study. It is thus reassuring 
that expert HPs identify the same gaps in RD education, 
and suggest similar approaches. One positive example 
is the ESE PARAT program – an initiative to uncover 
and address unmet educational and scientific needs in 
parathyroid disorders that also represent rare diseases 
(13). Another interesting example is the report presented 
by Cismondi   et  al. (14). The paradigm of single rare 
metabolic disease care was discussed during a workshop, 
concluding that efforts for improving care should begin 
with education, ultimately leading to the successful 
achievement of all goals. On the other hand, a study 
among Polish medical students showed not only a lack of 
knowledge but also a lack of interest in RD (15). Mathew 
formulates a few useful principles to be taught to students 
that enable them not to miss a rare condition while 
collecting history and examining a patient (16).
In the present study, the respondents considered 
correct diagnosing of RD as the most important task 
for them as medical professionals, while knowledge on 
available treatments and prognosis were considered most 
important for the patients. Social media was not viewed 
as an educational tool for doctors. As pointed out by 
Heon-Klin (17), the Networks need virtual cross-border 
highly-specialized health care advice services to overcome 
fragmentation and help HPs in their work with individual 
entities/patients. This has been implemented now by 
all ERNs by means of the Clinical Patient Management 
System (CPMS). CPMS allows for easy and safe patient 
consultations by multidisciplinary teams, and as such, 
also serves as a powerful educational tool providing direct 
access to the best expertise in Europe. Through CPMS, 
the ‘tacit knowledge’ (acquired through self-experience 
and high volume work) finds easy ways to merge with 
validated ‘explicit knowledge’ into higher competence 
(18), thus potentially improving RD care in a more 
efficient way based on cooperation.
According to the results of the present study, and in 
line with the literature, the time has come for structured 
theoretical and practical education on RD at all levels – 
for medical students, during postgraduate training and 
as continuous medical education in everyday practice. At 
the beginning of the ERNs, a major uncertainty was how 
to finance these programs. This uncertainty and hesitancy 
are also reflected in the current early survey. The only 
unconditional result is that educational activities must 
receive funding (100%), and >85% accentuated that this 
should be distributed through the Endo-ERN. Iskrov  et al. 
(17) proposed establishing postgraduate training programs 
devoted to RD, and provided alternative suggestions for 
financial stability.
Hiort   et  al. (19) presented experience from the 
educational activities of previous scientific actions with 
European financial support - the COST Actions DSDnet 
and GnRH Network, using specific instruments such as 
early career researchers short scientific missions and 
training schools. In addition, they defined the way-
forward for the ERNs to develop activities and extensive 
use of the European Joint Program Co-fund on RD research, 
education, and training (https ://ww w.ejp rared iseas es.or g/
ind ex.ph p/tra ining -and- empow ermen t/e-l earni ng/). The 
task is very challenging and there is compelling evidence 
that this cannot be executed outside the Expert centers/
respective Networks. A recent German study (20) tried 
to attract interest among physicians outside an expert 
center to metabolic RDs, offering education and mutual 
supported care for these patients with a formal contract, 
and supplying informational materials and yearly training. 
Intriguingly, although many of the invited physicians 
had already referred patients to this center, only 0.5% of 
them agreed to collaborate (20). The main reason not to 
participate was the expected very low number of patients 
at the doctors’ own practices.
A large study among Australian pediatricians caring 
for RD patients demonstrated that most participants 
felt unprepared for the challenges of such care (3). They 
desired one online portal through which the doctor could 
access many resources, similar to the results of the current 
survey. The participants in Endo-ERN prioritize a joint 
educational platform for RD, and accept streaming of 
knowledge through the Endo-ERN. Further collaboration 
with ESE and ESPE as well as possible links to the already 
existing ESE and ESPE e-platforms is important. Some of 
the requirements, such as slots at the scientific professional 
societies’ annual meetings and Endo-ERN webinars, have 
already been established. However, programs/instruments 
for knowledge and training/education assessment are still 
lacking universally (21), as well as specific patient materials 
(especially for children) and funding of activities. Fund-
raising is something that patient organizations are doing 
regularly. It seems that health care professionals should 
also not refrain from such activities (6). Increased funding 
for education and training at this historical moment for RD 
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in time should be pursued since the gathering of expertise 
within the Networks means boosting of knowledge and 
practice. Recent developments in the integrated care 
for RD stress that patients and their families should be 
directly engaged in decisions about their care (1), the basis 
of which again is knowledge.
Limitations of the current study include the possibility 
of specific language problems among respondents that 
could have resulted in some inconsistencies in answers. 
Assessment of patients’ educational means as perceived 
by HCPs has its limitations. WP1 has therefore recently 
performed another large survey among endocrine RD 
patients all over Europe (unpublished).
Strengths of the study include the highest possible 
experience of the respondents, as they are nationally 
endorsed for specific expertise senior health professionals 
to manage patients with rare endocrine disorders. With 
50% participation rate in the feasibility study where only 
highly motivated MTGs members took part, the response 
rate of 55% in the general survey was better than expected. 
Equal representation by profession, country, MTG, etc., 
the guaranteed validity of the results. We demonstrate 
that from the beginning, the approach and expectations 
of the respondents are similar regarding the educational 
and training aspects of the Network.
In conclusion, educational goals expected to be achieved 
by the Network include the transition and neonatal age, 
as well as assessment of and addressing the educational 
needs of patients. The identified knowledge gaps in rare 
endocrine disorders set the basis for their prompt closure 
through collaboration, alignment with patients’ needs and 
further development of existing educational platforms such 
as ESE and ESPE online learning tools and establishment of 
specific Endo-ERN resources that are underway.
Supplementary materials
This is linked to the online version of the paper at https://doi.org/10.1530/
EC-20-0480.
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